SI-BONE, Inc. (SIBN)
NASDAQ: SIBN · Real-Time Price · USD
15.21
-0.12 (-0.78%)
At close: Oct 8, 2025, 4:00 PM EDT
15.21
0.00 (0.00%)
After-hours: Oct 8, 2025, 4:10 PM EDT
SI-BONE Market Cap
SI-BONE has a market cap or net worth of $656.17 million as of October 8, 2025. Its market cap has increased by 2.26% in one year.
Market Cap
656.17M
Enterprise Value
550.58M
1-Year Change
2.26%
Ranking
Category
Stock Price
$15.21
Market Cap Chart
Since October 17, 2018, SI-BONE's market cap has increased from $218.80M to $656.17M, an increase of 199.89%. That is a compound annual growth rate of 17.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 661.35M | 12.48% |
| Dec 31, 2024 | 587.97M | -30.84% |
| Dec 29, 2023 | 850.12M | 81.20% |
| Dec 30, 2022 | 469.15M | -36.93% |
| Dec 31, 2021 | 743.81M | -23.13% |
| Dec 31, 2020 | 967.59M | 79.98% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 17, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 761.34B |
| Johnson & Johnson | 456.02B |
| AbbVie | 408.45B |
| UnitedHealth Group | 336.00B |
| AstraZeneca | 266.44B |
| Novo Nordisk | 261.01B |
| Novartis AG | 255.35B |
| Abbott Laboratories | 231.77B |